20th May, 2008
Speaker: Dr Chan Chin Pang Ian ( Resident Specialist, ICU, United Christian Hospital, Hong Kong )
Chairperson: Dr Lee Kar Lung ( SMO, ICU, United Christian Hospital, Hong Kong )
Reference:
1.Monterio H, Bechara EJH, Abdalla DSP. Free radicals involvement in neurological porphyrias and lead poisoning. Mol Cell Biochem 1991; 103: 73-84
2.Bonkovsky HL. Advances in understanding and treating "the little imitator", acute porphyria. Gastroenterology 1993; 105: 590-594
3.Lindberg RLP, Parcher C, Grandchamp B. Porphobilinogen deaminase deficiency in mice causes a neuropathy resembling that of human hepatic porphyria. Nat Genet 1996; 12: 195-199
4.http://www.drugs-porphyria.com
5.http://www.porphyria.uct.ac.za
6.http://www.porphyriafoundation.com
7.Doss M, Verspohl F: The "glucose effect" in acute hepatiac porphyrias and in experimental porphyria. Klin Wschr 9:727– 735, 1981
8.Andersson C, Bylesjo I, Lithner F: Effects of diabetes mellitus on patients with acute intermittent porphyria. J Intern Med 245:193–197, 1999